Supplementary Material for Shear et al.

Wu, X (via Mendeley Data)

September 2021

Supplementary Materials for "A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ra...

Supplemental material (Factors for Psoriatic Arthritis in Psoriasis patients)

Xie, W

This is additional supporting information for an article entitled "Modifiable Lifestyle and Environm...

Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Stein Gold, L

Mendeley Supplemental Figures and Table for Stein Gold et al. Efficacy and Safety of Apremilast in P...

Supplementary Material for Shear et al.

Shear, N

Supplemental material for the manuscript, "Comparative Safety and Benefit-Risk Profile of Biologics ...

Supplemental Material, Supplementary_Material_revised_Oct.10 - Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis

C. Cameron (6161996)
C. Druchok (6161999)
B. Hutton (3407222)
S. McElligott (6162002)
S. Nair (2497861)
A. Schubert (1703323)
A. Situ (6162005)
A. Varu (6162008)
R. Villacorta (6162011)

April 2019

Supplemental Material, Supplementary_Material_revised_Oct.10 for Guselkumab for the Treatment of Mod...

Table S1 -Supplemental material for Quantitative evaluation to efficacy and safety of therapies for psoriasis: A network meta-analysis

Jingjing Lv (5276036)
Dongmei Zhou (786550)
Yan Wang (15435)
Jingxia Zhao (5276045)
Zhaoxia Chen (5276039)
Jinchao Zhang (1324296)
Tingting Di (5276042)
Jing Hu (41899)
Bo Li (112195)
Ping Li (31981)
Feng Huang (62988)

May 2018

<p>Supplemental material, Table S1 for Quantitative evaluation to efficacy and safety of therapies f...

Placebo response meta-analysis - supplementary data

Egeberg, A (via Mendeley Data)

February 2019

Supplementary materials for the manuscript "Placebo response in phase 3 trials of systemic therapie...

Supplemental Materials for Stein Gold et al. A Phase 2b, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Plaque Psoriasis: Secondary Efficacy and Patient-Reported Outcomes. J Am Acad Dermatol. 2020.

Stein Gold, L

Mendeley Supplemental Tables and Figures for Stein Gold et al. A Phase 2b, Randomized Clinical Trial...

Supplemental Material, PRISMA_NMA_Checklist - Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis

C. Cameron (6161996)
C. Druchok (6161999)
B. Hutton (3407222)
S. McElligott (6162002)
S. Nair (2497861)
A. Schubert (1703323)
A. Situ (6162005)
A. Varu (6162008)
R. Villacorta (6162011)

April 2019

Supplemental Material, PRISMA_NMA_Checklist for Guselkumab for the Treatment of Moderate-to-Severe P...

Supplemental Materials for Stein Gold et al. A Phase IIb, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Plaque Psoriasis: Secondary Efficacy and Patient-Reported Outcomes. J Am Acad Dermatol. 2020.

Stein Gold, L (via Mendeley Data)

May 2020

Mendeley Supplemental Tables and Figures for Stein Gold et al. A Phase IIb, Randomized Clinical Tria...

SUPPLEMENTARY MATERIALS: Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, double-blinded, randomized, phase 3 POETYK PSO-2 trial

Strober, B

Supplementary materials for the publication of Strober B. Deucravacitinib versus placebo and apremil...

Supplemental Material - Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data

Jamie L. W. Rhoads (17603501)
William N. Malatestinic (9435331)
Russel Burge (3556160)
Michael L. Ganz (8429814)
Kristina C. Duffin (17603504)

December 2023

Supplemental Material for Factors Associated With Treatment Escalation for Psoriasis: An Analysis of...

Supplementary Material for "Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials"

Spencer, R (via Mendeley Data)

January 2023

Supplementary tables and figures for the paper titled "Comparative efficacy of biologics and or...

REVIEW Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses

Erica L. Baker
Craig I. Coleman
Kurt M. Reinhart
Olivia J. Phung
Lisa Kugelman
Wendy Chen
C. Michael
White Carla
M. Mamolo
William L. Baker

August 2016

The Author(s) 2012. This article is published with open access at Springerlink.com Introduction: The...

Online supplementary file 1 - Supplemental material for Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature

Amy Semaka (11281517)
Thomas G. Salopek (9605217)

August 2021

Supplemental material, Online supplementary file 1, for Risk of Developing Melanoma With Systemic Ag...

Supplementary Materials

Wu, X (via Mendeley Data)

September 2021

Supplementary Materials for "A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ra...

Supplemental material (Factors for Psoriatic Arthritis in Psoriasis patients)

Xie, W

This is additional supporting information for an article entitled "Modifiable Lifestyle and Environm...

Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Stein Gold, L

Mendeley Supplemental Figures and Table for Stein Gold et al. Efficacy and Safety of Apremilast in P...

Supplementary Material for Shear et al.

Shear, N

Supplemental material for the manuscript, "Comparative Safety and Benefit-Risk Profile of Biologics ...

Supplemental Material, Supplementary_Material_revised_Oct.10 - Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis

C. Cameron (6161996)
C. Druchok (6161999)
B. Hutton (3407222)
S. McElligott (6162002)
S. Nair (2497861)
A. Schubert (1703323)
A. Situ (6162005)
A. Varu (6162008)
R. Villacorta (6162011)

April 2019

Supplemental Material, Supplementary_Material_revised_Oct.10 for Guselkumab for the Treatment of Mod...

Table S1 -Supplemental material for Quantitative evaluation to efficacy and safety of therapies for psoriasis: A network meta-analysis

Jingjing Lv (5276036)
Dongmei Zhou (786550)
Yan Wang (15435)
Jingxia Zhao (5276045)
Zhaoxia Chen (5276039)
Jinchao Zhang (1324296)
Tingting Di (5276042)
Jing Hu (41899)
Bo Li (112195)
Ping Li (31981)
Feng Huang (62988)

May 2018

<p>Supplemental material, Table S1 for Quantitative evaluation to efficacy and safety of therapies f...

Placebo response meta-analysis - supplementary data

Egeberg, A (via Mendeley Data)

February 2019

Supplementary materials for the manuscript "Placebo response in phase 3 trials of systemic therapie...

Supplemental Materials for Stein Gold et al. A Phase 2b, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Plaque Psoriasis: Secondary Efficacy and Patient-Reported Outcomes. J Am Acad Dermatol. 2020.

Stein Gold, L

Mendeley Supplemental Tables and Figures for Stein Gold et al. A Phase 2b, Randomized Clinical Trial...

Supplemental Material, PRISMA_NMA_Checklist - Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis

C. Cameron (6161996)
C. Druchok (6161999)
B. Hutton (3407222)
S. McElligott (6162002)
S. Nair (2497861)
A. Schubert (1703323)
A. Situ (6162005)
A. Varu (6162008)
R. Villacorta (6162011)

April 2019

Supplemental Material, PRISMA_NMA_Checklist for Guselkumab for the Treatment of Moderate-to-Severe P...

Supplemental Materials for Stein Gold et al. A Phase IIb, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Plaque Psoriasis: Secondary Efficacy and Patient-Reported Outcomes. J Am Acad Dermatol. 2020.

Stein Gold, L (via Mendeley Data)

May 2020

Mendeley Supplemental Tables and Figures for Stein Gold et al. A Phase IIb, Randomized Clinical Tria...

SUPPLEMENTARY MATERIALS: Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, double-blinded, randomized, phase 3 POETYK PSO-2 trial

Strober, B

Supplementary materials for the publication of Strober B. Deucravacitinib versus placebo and apremil...

Supplemental Material - Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data

Jamie L. W. Rhoads (17603501)
William N. Malatestinic (9435331)
Russel Burge (3556160)
Michael L. Ganz (8429814)
Kristina C. Duffin (17603504)

December 2023

Supplemental Material for Factors Associated With Treatment Escalation for Psoriasis: An Analysis of...

Supplementary Material for "Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials"

Spencer, R (via Mendeley Data)

January 2023

Supplementary tables and figures for the paper titled "Comparative efficacy of biologics and or...

REVIEW Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses

Erica L. Baker
Craig I. Coleman
Kurt M. Reinhart
Olivia J. Phung
Lisa Kugelman
Wendy Chen
C. Michael
White Carla
M. Mamolo
William L. Baker

August 2016

The Author(s) 2012. This article is published with open access at Springerlink.com Introduction: The...

Online supplementary file 1 - Supplemental material for Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature

Amy Semaka (11281517)
Thomas G. Salopek (9605217)

August 2021

Supplemental material, Online supplementary file 1, for Risk of Developing Melanoma With Systemic Ag...

Supplementary Materials

Wu, X (via Mendeley Data)

September 2021

Supplementary Materials for "A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ra...

Supplemental material (Factors for Psoriatic Arthritis in Psoriasis patients)

Xie, W

This is additional supporting information for an article entitled "Modifiable Lifestyle and Environm...

Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Stein Gold, L

Mendeley Supplemental Figures and Table for Stein Gold et al. Efficacy and Safety of Apremilast in P...

Supplementary Material for Shear et al.

Abstract

Extracted data

Supplementary Material for Shear et al.

Abstract

Extracted data

Related items

Related items